首頁 > 市場調查報告書 > 醫療設備

醫院 IT 人工智能

市場調查報告書

商品編碼

1606545

全球醫療保健聊天機器人市場 - 2024-2031

Global Healthcare Chatbots Market - 2024-2031

出版日期: 2024年12月04日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

2023年，全球醫療保健聊天機器人市場規模達到6.8066億美元，預計2031年將達到34.8866億美元，2024-2031年預測期間複合年成長率為22.9%。

醫療聊天機器人也稱為醫療保健聊天機器人，是一種人工智慧驅動的對話解決方案，旨在使醫療保健更具互動性和主動性。這些聊天機器人可以顯著減少醫務人員收集和處理患者資訊、傳播醫療保健相關指南、確保患者參與等方面花費的時間，從而成為醫療保健系統的寶貴資產。

醫療保健聊天機器人充當患者與其醫療保健提供者之間的橋樑，通常是與診所、醫院或其他醫療保健組織的第一個聯繫點。想像一下這樣一個世界：您可以 24/7 隨時獲得個人化且高效的醫療保健支援。對於醫療保健聊天機器人的出現來說，這種情況並不是遙遠的未來，而是當前的現實。這些人工智慧驅動的虛擬助理正在改變醫療保健提供者與患者互動、管理資料和最佳化營運的方式。

醫療保健聊天機器人配備了人工智慧、神經合成人工智慧和自然語言處理 (NLP)，正在徹底改變病患照護和管理效率。他們協助完成諸如設定預約提醒、促進文件提交以及提供持續的患者支援等任務。透過探索醫療保健聊天機器人領域，我們將了解它們如何不僅滿足即時數位醫療保健互動的需求，而且在增強整個醫療保健行業方面發揮重要作用。這些因素推動了全球醫療保健聊天機器人市場的擴張。

市場動態：

驅動程式和限制

對虛擬健康援助的需求不斷增加

對虛擬健康援助的需求不斷成長，極大地推動了全球醫療保健聊天機器人市場的成長，預計將在整個市場預測期內推動成長。

消費者對醫療保健服務的態度發生了顯著變化。根據 TechTarget 2024 年 10 月的資料，顯示使用過虛擬醫療服務的消費者中有 94% 願意繼續使用這些選項。這種轉變在年輕人群中尤其明顯，43% 的千禧世代和 33% 的 Z 世代表示準備更換醫療保健提供者以改善虛擬就診選項。這一趨勢凸顯了人們對虛擬醫療服務提供的便利性和可近性的強烈偏好。

這場大流行大大加速了虛擬醫療解決方案的採用。根據美國國家生物技術資訊中心 (NCBI) 2022 年 5 月的資料，遠距醫療的使用量激增，報告顯示，與疫情前的水平相比，遠距醫療諮詢量增加了 230% 以上。當患者體驗到虛擬諮詢的好處時，許多人發現它們是傳統面對面諮詢的實用替代方案。即使行動限制有所放鬆，對遠距醫療服務的需求仍然很高，這表明這種轉變可能是永久性的。

對於患者和提供者來說，虛擬醫療服務都更具成本效益。患者可以節省交通費用和下班時間，而醫療服務提供者可以減少與實體辦公空間相關的間接費用。此外，虛擬健康可以幫助縮小獲得醫療服務的差距，特別是在醫療設施可能有限的農村或服務不足的地區。

人工智慧聊天機器人等先進技術的整合透過立即回應患者詢問、促進預約安排和提供症狀評估來提高虛擬醫療服務的有效性。這些技術提高了患者參與度並簡化了管理流程，使虛擬護理更有效率。所有這些因素都需要全球醫療保健聊天機器人市場。

此外，關鍵參與者的策略（例如夥伴關係和協作）將推動全球醫療保健聊天機器人市場的成長。例如，2024 年 7 月，GE 醫療保健與亞馬遜網路服務 (AWS) 之間的合作標誌著人工智慧 (AI) 在醫療保健領域的整合取得了重大進展，特別是在增強診斷流程方面。這種合作至關重要，因為它符合利用人工智慧技術（包括聊天機器人）來改善患者護理和臨床決策的日益成長的趨勢。

此外，2024 年 9 月，Hackensack Meridian Health 與 K Health 合作推出 HMH 24/7 虛擬初級保健服務，這是全球醫療保健聊天機器人市場的重大發展。這項舉措凸顯了人工智慧驅動的解決方案在醫療保健領域的日益整合，特別是在透過數位平台改善初級保健的可及性方面。所有這些因素都需要全球醫療保健聊天機器人市場。

此外，對人工智慧進步的需求不斷成長有助於全球醫療保健聊天機器人市場的擴張。

資料隱私問題

資料隱私問題是全球醫療保健聊天機器人市場的一個重大限制，影響了這些技術的採用和實施。隨著醫療保健聊天機器人變得越來越普遍，敏感患者資訊的管理引發了與安全性、合規性和可信性相關的關鍵問題。

醫療保健資料是最敏感的個人資訊類型之一。它包括病史、治療計劃和可識別健康資訊 (PHI) 等詳細資訊。未經授權披露或不當處理這些資料可能會導致嚴重後果，包括身分盜竊、歧視和失去患者信任。由於聊天機器人通常需要存取這些敏感資料來提供個人化服務，因此確保其保護至關重要。

根據美國國家生物技術資訊中心 (NCBI) 2023 年 11 月的研究出版物，人工智慧聊天機器人的使用需要收集和儲存大量個人資料，這引發了對資料安全和隱私的嚴重擔憂。人工智慧模型的有效運作依賴於持續的機器學習，其中涉及持續將大型資料集輸入回這些聊天機器人的神經網路中。如果用於訓練聊天機器人的資料包含敏感的患者或業務訊息，它將成為未來互動中使用的資料集的一部分。因此，這些資料可能會洩露給有意和無意的受眾，並在未經適當授權的情況下用於各種目的。

儘管人們認為人工智慧聊天機器人的能力有限，但它們具有巨大的潛力，可以從不同的資料來源收集新訊息，同時捕捉用戶回應。隨著越來越多的資料在網路上被收集和廣泛共享，確保資料的安全性和機密性變得越來越具有挑戰性。資訊量的不斷成長增加了保護敏感資料免遭未經授權的存取或濫用的難度。

此外，人工智慧聊天機器人可能會透過互動無意中暴露敏感資訊。例如，如果使用者將機密健康詳細資料或專有業務資訊輸入聊天機器人，則存在這些資料可能被儲存並隨後被未經授權的方存取的風險。這種情況強調需要採取嚴格的安全措施來保護個人資訊並維持使用者對這些技術的信任。因此，上述因素可能會限制全球醫療保健聊天機器人市場的潛在成長。

A medical chatbots, also known as healthcare chatbots, is an AI-powered conversational solution designed to make healthcare more interactive and proactive. These chatbots serve as valuable assets to the healthcare system by significantly reducing the time medical staff spend on collecting and processing patient information, disseminating healthcare-related guidelines, ensuring patient engagement, and more.

Healthcare chatbots act as a bridge between patients and their healthcare providers, often serving as the first point of contact with clinics, hospitals, or other healthcare organizations. Imagine a world where healthcare support is available 24/7 at your fingertips, personalized and efficient. This scenario is not a distant future but a current reality, to the emergence of healthcare chatbots. These AI-powered virtual assistants are transforming how healthcare providers interact with patients, manage data, and optimize operations.

Equipped with AI, neuro-synthetic AI, and natural language processing (NLP), healthcare chatbots are revolutionizing patient care and administrative efficiency. They assist with tasks such as setting appointment reminders, facilitating document submissions, and providing continuous patient support. By exploring the realm of healthcare chatbots, we will see how they not only meet the demand for immediate digital healthcare interactions but also play a significant role in enhancing the overall healthcare industry. These factors have driven the global healthcare chatbots market expansion.

Market Dynamics: Drivers & Restraints

Increasing Demand for Virtual Health Assistance

The increasing demand for virtual health assistance is significantly driving the growth of the global healthcare chatbots market and is expected to drive throughout the market forecast period.

There has been a marked change in consumer attitudes towards healthcare delivery. According to the TechTarget data in October 2024, indicate that 94% of consumers who have utilized virtual health services are willing to continue using these options. This shift is especially pronounced among younger demographics, with 43% of millennials and 33% of Generation Z expressing readiness to switch healthcare providers for improved virtual visit options. This trend underscores a strong preference for the convenience and accessibility that virtual health services provide.

The pandemic significantly accelerated the adoption of virtual healthcare solutions. As per National Center for Biotechnology Information (NCBI) data in May 2022, telemedicine usage surged, with reports indicating increases of over 230% in telemedicine consultations compared to pre-pandemic levels. As patients experienced the benefits of virtual consultations, many found them to be a practical alternative to traditional in-person visits. Even as mobility restrictions have eased, the demand for telehealth services remains high, suggesting that this shift may be permanent.

Virtual health services can be more cost-effective for both patients and providers. Patients save on transportation costs and time away from work, while providers can reduce overhead costs associated with physical office space. Additionally, virtual health can help bridge gaps in access to care, particularly in rural or underserved areas where medical facilities may be limited.

The integration of advanced technologies such as AI chatbots enhances the effectiveness of virtual health services by providing immediate responses to patient inquiries, facilitating appointment scheduling, and offering symptom assessments. These technologies improve patient engagement and streamline administrative processes, making virtual care more efficient. All these factors demand the global healthcare chatbots market.

Furthermore, key players' strategies such as partnerships and collaborations would drive this global healthcare chatbots market growth. For instance, in July 2024, the partnership between GE HealthCare and Amazon Web Services (AWS) marks a significant advancement in the integration of artificial intelligence (AI) within the healthcare sector, particularly in the context of enhancing diagnostic processes. This collaboration is pivotal as it aligns with the growing trend of utilizing AI technologies, including chatbots, to improve patient care and clinical decision-making.

Also, in September 2024, the partnership between Hackensack Meridian Health and K Health to launch the HMH 24/7 virtual primary care service is a significant development in the global healthcare chatbot market. This initiative highlights the increasing integration of AI-driven solutions in healthcare, particularly in improving access to primary care through digital platforms. All these factors demand the global healthcare chatbots market.

Moreover, the rising demand for the advancements in artificial intelligence contributes to the global healthcare chatbots market expansion.

Data Privacy Concerns

Data privacy concerns are a significant restraint in the global healthcare chatbots market, impacting the adoption and implementation of these technologies. As healthcare chatbots become more widespread, the management of sensitive patient information raises critical issues related to security, compliance, and trustworthiness.

Healthcare data is among the most sensitive types of personal information. It includes details such as medical histories, treatment plans, and identifiable health information (PHI). Unauthorized disclosure or mishandling of this data can lead to severe consequences, including identity theft, discrimination, and loss of patient trust. Since chatbots often require access to this sensitive data to deliver personalized services, ensuring its protection is crucial.

According to the National Center for Biotechnology Information (NCBI) research publication in November 2023, the use of AI chatbots necessitates the collection and storage of vast amounts of personal data, which raises significant concerns regarding data security and privacy. The effective operation of AI models relies on continuous machine learning, which involves consistently inputting large datasets back into the neural networks of these chatbots. If the data used to train a chatbot includes sensitive patient or business information, it becomes part of the dataset utilized in future interactions. Consequently, this data could potentially be disclosed to both intended and unintended audiences and used for various purposes without proper authorization.

Despite the perception that AI chatbots have limited capabilities, they possess a substantial potential to gather and collect new information from diverse data sources while capturing user responses. As more data is collected and shared widely across the internet, ensuring data security and confidentiality becomes increasingly challenging. The growing volume of information raises the difficulty of protecting sensitive data from unauthorized access or misuse.

Moreover, AI chatbots can inadvertently expose sensitive information through their interactions. For instance, if users input confidential health details or proprietary business information into a chatbot, there is a risk that this data could be stored and later accessed by unauthorized parties. This situation emphasizes the need for stringent security measures to safeguard personal information and maintain user trust in these technologies. Thus, the above factors could be limiting the global healthcare chatbots market's potential growth.

Segment Analysis

The global healthcare chatbots market is segmented based on component, deployment, application, end-user, and region.

Component:

The software segment is expected to dominate the global healthcare chatbots market share

The software segment holds a major portion of the global healthcare chatbots market share and is expected to continue to hold a significant portion of the global healthcare chatbots market share during the forecast period.

The software segment is expected to maintain its leading position as healthcare providers increasingly recognize the value of chatbot solutions in enhancing patient engagement and streamlining operations. Healthcare chatbots software often features versatile application programming interfaces (APIs) that facilitate integration with existing healthcare systems, such as electronic health records (EHRs). This integration supports better data management and continuity of care. Many chatbot providers adopt subscription-based pricing structures, offering freemium versions that can be upgraded to premium plans. This model encourages widespread adoption while generating consistent revenue streams for developers.

The ongoing development of chatbot software is propelled by advanced technological features that enhance functionality. Natural Language Processing (NLP) This technology allows chatbots to better understand and interpret user queries, facilitating more natural and effective interactions. The ability to communicate in multiple languages increases the accessibility of chatbots, catering to diverse patient populations. With the rise in smartphone usage, chatbots are increasingly designed to function seamlessly across various mobile platforms, improving user convenience.

Furthermore, key players in the industry product launches that would drive this segment growth in the global healthcare chatbots market. For instance, in April 2023, Sensely Labs announced the integration of ChatGPT into its Front Door Navigator product. This development represents a significant enhancement in how insurance policyholders can interact with their insurance providers, enabling them to receive intuitive answers to their most pressing queries quickly and efficiently.

Also, in October 2023, the launch of ten new health chatbots represents a significant advancement in healthcare technology, aimed at improving the lives of millions by providing accessible, personalized health information and support. These chatbots leverage artificial intelligence (AI) to assist users in managing their health proactively and navigating complex healthcare systems.

Similarly, in October 2023, Mendel.ai launched a chatbot specifically aimed at helping users manage and access their medical records. This innovative tool is designed to simplify the process of retrieving health information, making it more straightforward for patients to comprehend their medical history and treatment options. By utilizing advanced AI technology, the chatbot offers personalized responses to user inquiries, thereby enhancing patient engagement and improving communication between patients and healthcare providers. These factors have solidified the segment's position in the global healthcare chatbots market.

Geographical Analysis

North America is expected to hold a significant position in the global healthcare chatbots market share

North America holds a substantial position in the global healthcare chatbots market and is expected to hold most of the market share.

The increasing demand for accessible and efficient healthcare services is a significant driver in the North American healthcare chatbots market. Patients expect immediate access to healthcare information and services, mirroring the convenience they experience in other sectors such as retail and banking. Healthcare chatbots cater to this demand by providing 24/7 availability, allowing patients to seek medical advice, schedule appointments, and receive follow-up care without delay. This capability addresses traditional barriers to healthcare access, such as office hours and geographical limitations.

By enabling patients to interact with chatbots for routine inquiries and appointment scheduling, healthcare providers can significantly reduce waiting times in clinics and hospitals. This efficiency enhances patient satisfaction and improves overall care delivery. The rapid advancement of artificial intelligence (AI) and natural language processing (NLP) technologies has made chatbots more capable of handling complex medical inquiries. These technologies allow chatbots to understand context, interpret user queries accurately, and provide personalized responses.

Furthermore, in this region, a major number of key players' presence, well-advanced healthcare infrastructure, government initiatives & regulatory support, and product launches would propel this global healthcare chatbots market. For instance, in September 2023, HealthTap, a prominent virtual healthcare provider in the U.S., launched an enhanced version of its Dr.A.I. feature, which utilizes OpenAI's GPT-4 technology. This innovative tool is designed to streamline the patient interview process before medical appointments, enabling a more efficient and personalized healthcare experience.

Also, in September 2024, the International Myeloma Foundation (IMF) proudly launched Myelo, the first AI-powered responsive chatbot designed to serve as a virtual assistant for patients, care partners, and healthcare professionals dealing with multiple myeloma. This innovative tool aims to enhance the support and resources available to individuals affected by this complex disease.

Similarly, in April 2024, the Advanced Research Projects Agency for Health (ARPA-H) launched the Chatbot Accuracy and Reliability Evaluation (CARE) Exploration Topic (ET) to enhance the development and evaluation of chatbots used in patient-facing applications. This initiative is crucial given the increasing reliance on digital health tools, especially as more than half of American households utilize the Internet for health-related activities, including researching medical information. Thus, the above factors are consolidating the region's position as a dominant force in the global healthcare chatbots market.

Asia Pacific is growing at the fastest pace in the global healthcare chatbots market share

Asia Pacific holds the fastest pace in the global healthcare chatbots market and is expected to hold most of the market share.

The Asia-Pacific healthcare chatbots market is witnessing significant growth, primarily driven by rapid digitalization in the healthcare sector and advancements in artificial intelligence (AI) and natural language processing (NLP).

The healthcare landscape in the Asia-Pacific region is undergoing a profound transformation due to digitalization. This shift involves the adoption of digital technologies aimed at improving healthcare delivery, streamlining operations, and enhancing patient experiences. Healthcare chatbots are increasingly integrated into existing digital health platforms, enabling seamless communication between patients and providers. This integration enhances overall efficiency in healthcare delivery.

The continuous evolution of AI and NLP technologies significantly boosts the capabilities of healthcare chatbots. These advancements allow chatbots to provide more accurate and personalized health assistance, which is crucial in the diverse Asia-Pacific region. With advancements in NLP, chatbots can better comprehend and interpret complex medical inquiries. This capability enables them to respond accurately to patient questions, resulting in a more satisfying user experience.

Furthermore, in this region, key player's initiatives, key developments, and product launches would drive the global healthcare chatbots market growth. For instance, in March 2024, The Centre for Artificial Intelligence and Robotics (CAIR), part of the Chinese Academy of Sciences (CAS), developed a large language model-based chatbot specifically designed to assist doctors in making medical diagnoses and treatment decisions. This initiative reflects a growing trend in leveraging artificial intelligence to enhance healthcare delivery and improve clinical outcomes.

Also, in April 2024, Fortis Healthcare launched an AI-powered chatbot designed to assist individuals grappling with mental health challenges in India. Named "Adayu Mindfulness," the app offers psychological support akin to a first aid kit, specially tailored for those hesitant to seek professional help due to societal stigma. Stella, the AI chatbot embedded within the app, engages users in conversation and recommends self-assessment tools to help them understand their mental health status.

Similarly, in November 2024, the Ayushman Bharat Digital Mission (ABDM) launched a WhatsApp Chatbot designed to provide citizens with quick and easy access to healthcare information directly through the popular messaging platform. This initiative aims to enhance digital health guidance by making it readily available to users, thereby improving their ability to obtain essential health-related information.

Additionally, in June 2023, DocPlix launched Panini, an AI-powered chatbot specifically designed by doctors for doctors, aiming to enhance clinical practice by improving diagnostic precision, accelerating complex computations, and reducing medical judgment errors. The launch event was attended by over 250 top physicians in India, marking a significant milestone in the healthcare industry. Thus, the above factors are consolidating the region's position as the fastest-growing force in the global healthcare chatbots market.

Competitive Landscape

The major global players in the healthcare chatbots market include Your.MD Ltd., HealthTap, Inc., Sensely, Inc., Buoy Health, Inc., Infermedica, Ada Health GmbH, PACT Care BV., Woebot Health, GYANT, and Kenyt Inc. others.

Key Developments

In November 2024, HealthSci.AI launched a revolutionary suite of health-focused and biotech-driven chatbots designed to empower users with personalized guidance and support across a wide array of health and biotechnology topics. This initiative aims to create an accessible pathway for individuals to proactively manage their health and navigate the complexities of biotechnology with confidence.
In January 2024, Kauvery Hospital launched Floatbot, an advanced AI-driven chatbot on its website, aimed at enhancing patient care and engagement. This initiative reflects the growing trend of utilizing chatbot technology in the healthcare sector to automate various tasks and improve the overall patient experience. Floatbot simplifies the often-lengthy process of scheduling appointments. Patients can quickly book their visits through the chatbot, reducing wait times and streamlining administrative workflows for the hospital.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global healthcare chatbots market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Component
3.2. Snippet by Deployment
3.3. Snippet by Application
3.4. Snippet by End-User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing Demand for Virtual Health Assistance
- 4.1.2. Restraints
  - 4.1.2.1. Data Privacy Concerns
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Patent Analysis
5.5. Regulatory Analysis
5.6. SWOT Analysis
5.7. Unmet Needs

6. By Component

6.1. Introduction
- 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Component
- 6.1.2. Market Attractiveness Index, By Component
6.2. Software*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Services

7. By Deployment

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment
- 7.1.2. Market Attractiveness Index, By Deployment
7.2. Cloud*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. On-Premise

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Symptom Checking*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Appointment Scheduling & Monitoring
8.4. Medical & Drug Information Assistance
8.5. Others

9. By End-User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.1.2. Market Attractiveness Index, By End-User
9.2. Patients*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Insurance companies
9.4. Healthcare providers
9.5. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.7.1. U.S.
  - 10.2.7.2. Canada
  - 10.2.7.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.7.1. Germany
  - 10.3.7.2. U.K.
  - 10.3.7.3. France
  - 10.3.7.4. Spain
  - 10.3.7.5. Italy
  - 10.3.7.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.7.1. Brazil
  - 10.4.7.2. Argentina
  - 10.4.7.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.7.1. China
  - 10.5.7.2. India
  - 10.5.7.3. Japan
  - 10.5.7.4. South Korea
  - 10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Your.MD Ltd. *
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. HealthTap, Inc.
12.3. Sensely, Inc.
12.4. Buoy Health, Inc.
12.5. Infermedica
12.6. Ada Health GmbH
12.7. PACT Care BV.
12.8. Woebot Health
12.9. GYANT
12.10. Kenyt Inc.

LIST NOT EXHAUSTIVE